SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $172M invested in SPDR S&P Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 80 → 79 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
79
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$4.55M | |
| 2 | +$3.92M | |
| 3 | +$1.15M | |
| 4 |
Morgan Stanley
New York
|
+$1M |
| 5 |
OLA
Oliver Luxxe Assets
Gladstone,
New Jersey
|
+$964K |
Top Sellers
| 1 | -$3.99M | |
| 2 | -$2.45M | |
| 3 | -$1.55M | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.09M |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$1.03M |